In the news
‘The price is bewildering’: The cost of Biogen’s Alzheimer’s drug may lead payers to erect roadblocks
June 7, 2021STAT News
Related news
In the news
December 19, 2022
How to Ascend in Your Career (With Erin Feigal)
People Make it Possible podcast
In the news
December 16, 2022
Prime Therapeutics joins other PBMs in adding Humira biosimilars
Becker’s Payer Issues
In the news
December 16, 2022
Kroger Health Makes Deal to Remain In-Network With Prime Therapeutics
Progressive Grocer